No one should have to die of cancer
Mission-oriented innovation in cancer control – watch our video on why and how Vision Zero Cancer works mission oriented, making sure diverse actors meet so that we together can reorient and adapt for a healthier and more sustainable future!
News
17 April 2024 11:38
Brace Yourself for Impact – in Precision Medicine Implementation08 February 2024 17:52
Lung cancer policy network meets our co-founder19 October 2023 10:27
Workshop on “Measuring Impact” at House of Innovation26 September 2023 11:25
Official Opening of the Horizon EU Cancer Mission PRIME-ROSE project15 September 2023 10:07
Nordic Precision Cancer Medicine Conference26 June 2023 09:58
Launch new website for Testbed Sweden Precision Health CancerInternational collaborations, Workshops
Brace Yourself for Impact – in Precision Medicine Implementation
On April 23rd-24th, Vision Zero Cancer/ SIR will be at the Nordic Precision Medicine Forum in Stockholm and organise a workshop on impact assessment frameworks for Precision Medicine implementation.
Interview, Lungcancer
Lung cancer policy network meets our co-founder
Lung cancer policy network meets with to Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer, a mission-oriented innovation hub coordinated by Stockholm School of Economics Institute for Research, Sweden
Testbed Sweden Precision Health Cancer
Cancer is one of society’s greatest global challenges. To meet it, Vision Zero Cancer, Genomic Medicine Sweden (GMS) and SciLifeLab joined forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create the innovation hub Testbed Sweden for Precision Health in Cancer.
International community
PCM4EU
Personalised Cancer Medicine for Europe, PCM4EU, is a project under the Europe’s Beating Cancer Plan by EU4Health. PCM4EU is about facilitating implementation of molecular cancer diagnostics for precision oncology, and the consortium consists of partners from altogether 15 countries across Europe.
PRIME-ROSE
A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The PRIME-ROSE project builds on a bottom-up, clinician-initiated family of PCM clinical trials which have been particularly successful in bringing up inclusion rates to offer additional lines of treatment and in providing patient benefit.
ECHoS
ECHoS (Establishing Cancer Mission Hubs: Networks and Synergies) is a project aiming to ensure the implementation of the Cancer Mission activities in all member states by establishing and developing Cancer Mission Hubs operating at national, regional, and local levels.